Institute of Pharmacology & Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
School of Pharmacy, Hangzhou Medical College, Hangzhou, China.
CNS Neurosci Ther. 2023 Dec;29(12):3684-3692. doi: 10.1111/cns.14353. Epub 2023 Jul 12.
Mania is a prevalent psychiatric disorder with undefined pathological mechanism. Here, we reviewed current knowledge indicating the potential involvement of autophagy dysregulation in mania and further discussed whether targeting autophagy could be a promising strategy for mania therapy.
Accumulating evidence indicated the involvement of autophagy in the pathology of mania. One of the most well-accepted mechanisms underlying mania, circadian dysregulation, showed mutual interaction with autophagy dysfunction. In addition, several first-line drugs for mania therapy were found to regulate neuronal autophagy. Besides, deficiencies in mitochondrial quality control, neurotransmission, and ion channel, which showed causal links to mania, were intimately associated with autophagy dysfunction.
Although more efforts should be made to either identify the key pathology of mania, the current evidence supported that autophagy dysregulation may act as a possible mechanism involved in the onset of mania-like symptoms. It is therefore a potential strategy to treat manic disorder by correting autophagy.
躁狂是一种常见的精神疾病,其病理机制尚未明确。本文综述了目前关于自噬失调可能参与躁狂症的相关知识,并进一步探讨了靶向自噬是否可能成为治疗躁狂症的一种有前途的策略。
越来越多的证据表明自噬参与了躁狂症的发病机制。躁狂症最被广泛接受的发病机制之一——昼夜节律失调,与自噬功能障碍相互作用。此外,几种治疗躁狂症的一线药物被发现可调节神经元自噬。此外,与躁狂症有因果关系的线粒体质量控制、神经递质和离子通道缺陷与自噬功能障碍密切相关。
尽管还需要进一步努力确定躁狂症的关键病理,但目前的证据表明,自噬失调可能是一种参与类似躁狂症状发生的潜在机制。因此,通过纠正自噬来治疗躁狂症可能是一种有前途的策略。